Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Effects of Acthar on Recovery From Cognitive Relapses in MS [Phase 3]
Phase 3 trial evaluating Acthar for recovery from cognitive relapses in multiple sclerosis has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis [NA]
Completed clinical trial assessing transcranial direct current stimulation (tDCS) for cognition in adults with multiple sclerosis or encepha…
-
FDA approval · 2020-03-27FDA Approved: AVONEX — Supplemental Application (Biogen Inc.)
FDA approved a supplemental application for Avonex (interferon beta-1a) by Biogen, resulting in a modification to the existing label.
-
FDA approval · 2020-03-27FDA Approved: PLEGRIDY PEN — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for the PLEGRIDY PEN autoinjector, delivering peginterferon beta-1a for relapsing forms o…
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial [Phase 2]
Phase 2 multi-arm randomized trial in secondary progressive multiple sclerosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-03-25FDA Approved: ZEPOSIA 7-DAY STARTER PACK — Original Application (Celgene Corporation)
FDA approved Zeposia 7-day starter pack containing ozanimod hydrochloride under the Original Application for Celgene Corporation. The starte…
-
FDA approval · 2020-03-24FDA Approved: TIZANIDINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of tizanidine hydrochloride from Aurobindo Pharma Limited via Original Application (ANDA 213544) for the trea…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes [Phase 4]
Phase 4 trial update evaluating Tecfidera (dimethyl fumarate) on multiple sclerosis disease activity and patient-reported outcomes has compl…
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS) [Phase 2]
Phase 2 trial update for RETAIN-MS evaluating atomoxetine treatment in memory disorders associated with multiple sclerosis; study completed …
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis [Phase 2, Phase 3]
A clinical trial update for NeuroVax, a therapeutic TCR peptide vaccine being studied in secondary progressive and general multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update for NeuroVax, a novel TCR peptide vaccine for secondary progressive multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study [Phase 2]
Phase 2 proof-of-concept trial investigating intravenous autologous mesenchymal stem cells for multiple sclerosis showed safety and efficacy…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment [Phase 1, Phase 2]
Phase 1/2 trial evaluating allogeneic mesenchymal stem cells plus physical therapy for multiple sclerosis has completed.
-
FDA approval · 2020-02-28FDA Approved: AUBAGIO — Supplemental Application (Genzyme Corporation)
The FDA approved a supplemental application for AUBAGIO (teriflunomide) submitted by Genzyme Corporation. This action updates the approved l…
-
FDA approval · 2020-02-28FDA Approved: TERIFLUNOMIDE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original ANDA for teriflunomide by Mylan Pharmaceuticals, enabling the generic version to be marketed.
-
FDA approval · 2020-02-09FDA Approved: TERIFLUNOMIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals’ supplemental application for teriflunomide (generic) under ANDA209572, enabling its marketing for mult…
-
FDA approval · 2020-02-05FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for TECFIDERA (dimethyl fumarate).
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis
A completed clinical trial studied medical marijuana and its effects on motor function in people with multiple sclerosis, with results poste…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Can Transcranial Direct Current Stimulation Improve Ambulation and Fatigue Resistance in People With MS? [NA]
A completed clinical trial evaluating whether transcranial direct current stimulation can improve ambulation and fatigue resistance in peopl…
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: Ampyra for Optic Neuritis in Multiple Sclerosis [Phase 2, Phase 3]
Phase 2/Phase 3 trial update for Ampyra in optic neuritis associated with multiple sclerosis; results have been posted following completion.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: To Study the Pathophysiological Features of Multiple Sclerosis [Phase 1, Phase 2]
An early-phase clinical trial update investigating the pathophysiology of multiple sclerosis, with focus on neurofilament light chain and gl…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Treating Anorectal Dysfunction in MS [Phase 2]
Phase 2 trial update for treating anorectal dysfunction in multiple sclerosis; study terminated with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Adherence in Pediatric Multiple Sclerosis [NA]
A completed pediatric multiple sclerosis trial results posted in 2020, focusing on adherence.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis [Phase 2]
Phase 2 trial update examining high-dose chemotherapy/radiotherapy followed by hematopoietic stem cell transplant for multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Safety of Switching From Rituximab to Ocrelizumab in MS Patients [Phase 3]
Clinical trial update evaluating safety of switching from Rituximab to Ocrelizumab in multiple sclerosis patients (Phase 3).